Johannes Fruehauf
Founder and Chairman
LabCentralCambridge, Massachusetts, United States
15 investmentsJohannes Fruehauf is a Founder and Chairman at LabCentral based in Cambridge, Massachusetts, United States. Johannes Fruehauf has backed 15 companies, including Sentieon, Vaxess Technologies and Volnay Therapeutics. Investment focus areas include Health Care, Research and Development and Wellness.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (16)
| 1 | Sentieon |
| 2 | Vaxess Technologies |
| 3 | Volnay Therapeutics |
| 4 | Zag Bio |
| 5 | Sentien Biotechnologies |
| 6 | Inc. |
| 7 | Chlorion Pharma |
| 8 | Pandion Therapeutics |
| 9 | Cequent Pharmaceuticals (now Marina Biotech NASDAQ: MRNA) |
| 10 | QurAlis |
| 11 | Tidal Therapeutics |
| 12 | Pegase Medical |
Showing 1–12 of 16
Page 1 of 2
Access Full Contact Information
Get Johannes Fruehauf's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.